S.I. Sherman, Thyroid carcinoma. Lancet 361(9356), 501–511 (2003)

Article  PubMed  Google Scholar 

Z.W. Baloch, S.L. Asa, J.A. Barletta, R.A. Ghossein, C.C. Juhlin, C.K. Jung et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr. Pathol. 33(1), 27–63 (2022)

Article  PubMed  Google Scholar 

B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1), 1–133 (2016)

Article  PubMed  PubMed Central  Google Scholar 

G. Rondeau, S. Fish, L.E. Hann, J.A. Fagin, R.M. Tuttle, Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression. Thyroid 21(8), 845–853 (2011)

Article  PubMed  PubMed Central  Google Scholar 

A. Frasoldati, M. Pesenti, M. Gallo, A. Caroggio, D. Salvo, R. Valcavi, Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97(1), 90–96 (2003)

Article  PubMed  Google Scholar 

M. Torlontano, U. Crocetti, G. Augello, L. D’Aloiso, N. Bonfitto, A. Varraso et al. Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. J. Clin. Endocrinol. Metab. 91(1), 60–63 (2006)

Article  CAS  PubMed  Google Scholar 

American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009)

Article  Google Scholar 

R.M. Tuttle, H. Tala, J. Shah, R. Leboeuf, R. Ghossein, M. Gonen et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 20(12), 1341–1349 (2010)

Article  CAS  PubMed  PubMed Central  Google Scholar 

F.A. Verburg, U. Mäder, L. Giovanella, M. Luster, C. Reiners, Low or undetectable basal thyroglobulin levels obviate the need for neck ultrasound in differentiated thyroid cancer patients after total thyroidectomy and 131I ablation. Thyroid 28(6), 722–728 (2018)

Article  CAS  PubMed  Google Scholar 

P.W. Rosario, G.F. Mourão, M.R. Calsolari, Repeat ultrasonography in the first years after therapy with radioiodine is not necessary in most patients with papillary thyroid carcinoma when postoperative ultrasonography is negative: a reduction of costs and false-positives. Eur. Thyroid J. 8(1), 41–45 (2019)

Article  PubMed  Google Scholar 

K.S.Y. Sek, I. Tsang, X.Y. Lee, O.H. Albaqmi, Y.J. Morosan Allo, M.C. Rosmarin et al. Frequent neck US in papillary thyroid cancer likely detects non-actionable findings. Clin. Endocrinol. 94(3), 504–512 (2021)

Article  CAS  Google Scholar 

S. Epstein, R. McEachern, R. Khot, S. Padia, J.T. Patrie, J.N. Itri, Papillary thyroid carcinoma recurrence: low yield of neck ultrasound with an undetectable serum thyroglobulin level. J. Ultrasound Med. 37(10), 2325–2331 (2018)

Article  PubMed  Google Scholar 

S. Peiling Yang, A.M. Bach, R.M. Tuttle, S.A. Fish, Frequent screening with serial neck ultrasound is more likely to identify false-positive abnormalities than clinically significant disease in the surveillance of intermediate risk papillary thyroid cancer patients without suspicious findings on follow-up ultrasound evaluation. J. Clin. Endocrinol. Metab. 100(4), 1561–1567 (2015)

Article  PubMed  PubMed Central  Google Scholar 

S.P. Yang, A.M. Bach, R.M. Tuttle, S.A. Fish, Serial neck ultrasound is more likely to identify false-positive abnormalities than clinically significant disease in low-risk papillary thyroid cancer patients. Endocr. Pract. 21(12), 1372–1379 (2015)

Article  PubMed  PubMed Central  Google Scholar 

L. Leenhardt, M.F. Erdogan, L. Hegedus, S.J. Mandel, R. Paschke, T. Rago et al. 2013 European Thyroid Association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur. Thyroid J. 2(3), 147–159 (2013)

Article  CAS  PubMed  PubMed Central  Google Scholar 

I. Pałyga, M. Rumian, A. Kosel, M. Albrzykowski, P. Krawczyk, A. Kalwat et al. The frequency of differentiated thyroid cancer recurrence in 2302 patients with excellent response to primary therapy. J. Clin. Endocrinol. Metab. 109(2), e569–e578 (2024)

Article  PubMed  Google Scholar 

M. Schlumberger, S. Leboulleux, B. Catargi, D. Deandreis, S. Zerdoud, S. Bardet et al. Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial. Lancet Diabetes. Endocrinol. 6(8), 618–626 (2018)

Article  PubMed  Google Scholar 

H.M. Dehbi, U. Mallick, J. Wadsley, K. Newbold, C. Harmer, A. Hackshaw, Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial. Lancet Diabetes Endocrinol. 7(1), 44–51 (2019)

Article  CAS  PubMed  PubMed Central  Google Scholar 

G. Grani, V. Ramundo, R. Falcone, L. Lamartina, T. Montesano, M. Biffoni et al. Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound. J. Clin. Endocrinol. Metab. 104(11), 4981–4989 (2019)

Article  PubMed  Google Scholar 

S. Censi, A. De Rosa, F. Galuppini, J. Manso, L. Bertazza, I. Merante-Boschin et al. Can ultrasensitive thyroglobulin immunoassays avoid the need for ultrasound in thyroid cancer follow-up? Endocrine 75(3), 837–845 (2022)

Article  CAS  PubMed  Google Scholar 

M. Torlontano, M. Attard, U. Crocetti, S. Tumino, R. Bruno, G. Costante et al. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J. Clin. Endocrinol. Metab. 89(7), 3402–3407 (2004)

Article  CAS  PubMed  Google Scholar 

A. Matrone, C. Gambale, P. Piaggi, D. Viola, C. Giani, L. Agate et al. Postoperative thyroglobulin and neck ultrasound in the risk restratification and decision to perform 131I ablation. J. Clin. Endocrinol. Metab. 102(3), 893–902 (2017)

PubMed  Google Scholar 

J.L. Gray, G. Singh, L. Uttley, S.P. Balasubramanian, Routine thyroglobulin, neck ultrasound and physical examination in the routine follow up of patients with differentiated thyroid cancer-Where is the evidence? Endocrine 62(1), 26–33 (2018)

Article  CAS  PubMed  PubMed Central  Google Scholar